Fibromodulin (encoded by FMOD) is thought to be involved in the inhibition of tumorigenesis and apoptosis in hematologic malignancies such as B-cell chronic lymphocytic leukemia and mantle cell lymphoma, like other proteoglycans (40). This evidence concerns the gene FMOD and hematologic disorder.